Timolol | Annual Sales Report | Pharmacompass.com

Please Wait

Applying Filters...

Timolol

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

42 API Suppliers, 18 USDMF, 10 CEP/COS, 7 JDMF, 4 EU WC, 20 KDMF, 13 NDC API, 27 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

7 Drugs in Development

7 Drugs in Development

FINISHED DOSAGE FORMULATIONS

505 FDF Dossiers, 118 FDA Orange Book, 281 Europe, 38 Canada, 6 Australia, 24 South Africa, 38 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION/DROPS;OPHTHALMIC - EQ 0.25% BASE, SOLUTION/DROPS;OPHTHALMIC - EQ 0.5% BASE, SOLUTION/DROPS;OPHTHALMIC - EQ 0.25% BASE, SOLUTION/DROPS;OPHTHALMIC - EQ 0.5% BASE, SOLUTION, GEL FORMING/DROPS;OPHTHALMIC - EQ 0.25% BASE, SOLUTION, GEL FORMING/DROPS;OPHTHALMIC - EQ 0.5% BASE, SOLUTION/DROPS;OPHTHALMIC - EQ 2% BASE;EQ 0.5% BASE, SOLUTION/DROPS;OPHTHALMIC - EQ 0.5% BASE

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 16 SPI Pharma, 7 DKSH, 1 Pharm-RX Chemical, 5 Faran Shimi Pharmaceutical, 10 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 9 Actylis, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 7 BASF, 1 BioSpectra, 3 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 6 Kerry, 9 Microlex e.U, 1 Nanjing Bold Chemical, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 16 Roquette, 7 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

49 Fillers, Diluents & Binders, 30 Direct Compression, 21 Thickeners and Stabilizers, 18 Disintegrants & Superdisintegrants, 16 Co-Processed Excipients, 15 Parenteral, 15 Taste Masking, 14 Granulation, 14 Chewable & Orodispersible Aids, 13 Lubricants & Glidants, 12 Solubilizers, 11 Topical, 8 Rheology Modifiers, 8 Controlled & Modified Release, 6 Emulsifying Agents, 5 Coating Systems & Additives, 4 API Stability Enhancers, 3 Film Formers & Plasticizers, 3 Surfactant & Foaming Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 37 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 260 Finished Drug Prices, 7 Annual Reports

MARKET PLACE

19 APIs, 4 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 Health Canada Patents

3 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 5 USP, 14 Others

$ Xls

Filters

Filters

FILTER :

filter Product Reset all filters

7 All

01 5Alphagan/Combigan

02 2Xalabrands

List of Suppliers

Product Main Page

01

Brand Name : Alphagan/Combigan

Medlab Asia & Asia Health

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Timolol Maleate

Main Therapeutic Indication : Ophthalmology

Currency : USD

2020 Revenue in Millions : 326

2019 Revenue in Millions : 0

Growth (%) : 100

Abbvie Company Banner

Product Web Link

Digital Content

Corporate PDF

02

Brand Name : Alphagan/Combigan

Medlab Asia & Asia Health

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Timolol Maleate

Main Therapeutic Indication : Ophthalmology

Currency : USD

2021 Revenue in Millions : 529

2020 Revenue in Millions : 326

Growth (%) : 62

Abbvie Company Banner

Product Web Link

Digital Content

Corporate PDF

03

Brand Name : Alphagan/Combigan

Medlab Asia & Asia Health

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Timolol Maleate

Main Therapeutic Indication : Ophthalmology

Currency : USD

2022 Revenue in Millions : 346

2021 Revenue in Millions : 529

Growth (%) : -35

Abbvie Company Banner

Product Web Link

Digital Content

Corporate PDF

04

Brand Name : Alphagan/Combigan

Medlab Asia & Asia Health

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Timolol Maleate

Main Therapeutic Indication : Ophthalmology

Currency : USD

2023 Revenue in Millions : 272

2022 Revenue in Millions : 346

Growth (%) : -21

Abbvie Company Banner

Product Web Link

Digital Content

Corporate PDF

05

Brand Name : Alphagan/Combigan

Medlab Asia & Asia Health

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Timolol Maleate

Main Therapeutic Indication : Ophthalmology

Currency : USD

2019 Revenue in Millions : 522

2018 Revenue in Millions : 551

Growth (%) : -5

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Brand Name : Xalabrands

Medlab Asia & Asia Health

Not Confirmed

07

Brand Name : Xalabrands

Medlab Asia & Asia Health

Not Confirmed

Contact us
to update this info